Viemed Healthcare Inc (VMD)
7.27 -0.01 (-0.14%) 11:52 ET [NASDAQ]
7.24 x 7 7.34 x 100
Realtime by (Cboe BZX)
7.24 x 7 7.34 x 100
Realtime - - (-) -
for Tue, Apr 1st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 17,540 | 11,347 | 8,807 | 7,309 | 12,839 |
Receivables | 24,911 | 27,051 | 27,509 | 24,477 | 18,451 |
Inventories | 4,320 | 4,311 | 4,424 | 4,349 | 4,628 |
TOTAL | $52,880 | $47,698 | $44,975 | $38,618 | $38,367 |
Non-Current Assets | |||||
PPE Net | 76,279 | 74,397 | 74,701 | 73,511 | 73,579 |
Investments And Advances | 2,794 | 2,669 | 2,794 | 3,972 | 3,899 |
Intangibles | 33,837 | 33,869 | 33,901 | 30,299 | 30,332 |
Other Non-Current Assets | 11,279 | 10,893 | 7,576 | 8,475 | 8,718 |
TOTAL | $124,189 | $121,828 | $118,972 | $116,257 | $116,528 |
Total Assets | $177,069 | $169,526 | $163,947 | $154,875 | $154,895 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 409 | 812 | 772 | 596 | 1,072 |
Accounts payable and accrued liabilities | 5,322 | 6,007 | 6,334 | 5,800 | 4,180 |
Accrued Expenses | 20,157 | 19,918 | 16,801 | 14,057 | 17,578 |
TOTAL | $37,326 | $36,444 | $31,478 | $30,117 | $32,124 |
Non-Current Liabilities | |||||
Long Term Debt | 3,589 | 3,650 | 8,715 | 5,906 | 6,002 |
Deferred Revenues | 6,694 | 6,819 | 6,723 | 6,092 | 6,207 |
aiOther Non-Current Liabilities | 2,745 | 2,610 | 2,537 | 2,484 | 2,742 |
TOTAL | $6,442 | $6,287 | $11,289 | $8,485 | $8,876 |
Total Liabilities | $43,768 | $42,731 | $42,767 | $38,602 | $41,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 39,522 | 38,937 | 38,826 | 38,821 | 38,757 |
Common Shares | 23,365 | 22,749 | 21,910 | 21,842 | 18,702 |
Retained earnings | 89,691 | 85,379 | 81,594 | 80,137 | 79,495 |
Other shareholders' equity | 1,908 | 1,836 | 1,809 | 0 | 0 |
TOTAL | $133,301 | $126,795 | $121,180 | $116,273 | $113,895 |
Total Liabilities And Equity | $177,069 | $169,526 | $163,947 | $154,875 | $154,895 |